Cargando…
SARS-CoV-2 journey to the brain with a focus on potential role of docosahexaenoic acid bioactive lipid mediators
Coronavirus Disease 2019 or COVID-19 have infected till day 82,579,768 confirmed cases including 1,818,849 deaths, reported by World Health Organization WHO. COVID-19, originated by Severe Acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), contributes to respiratory distress in addition to neuro...
Autor principal: | Hachem, Mayssa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM).
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904461/ https://www.ncbi.nlm.nih.gov/pubmed/33639198 http://dx.doi.org/10.1016/j.biochi.2021.02.012 |
Ejemplares similares
-
Emerging Role of Phospholipids and Lysophospholipids for Improving Brain Docosahexaenoic Acid as Potential Preventive and Therapeutic Strategies for Neurological Diseases
por: Hachem, Mayssa, et al.
Publicado: (2022) -
Omega-3 Docosahexaenoic Acid Is a Mediator of Fate-Decision of Adult Neural Stem Cells
por: Lo Van, Amanda, et al.
Publicado: (2019) -
From Pandemicity to Endemicity: The Journey of SARS-CoV-2
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2022) -
Docosahexaenoic Acid (DHA) Bioavailability in Humans after Oral Intake of DHA-Containing Triacylglycerol or the Structured Phospholipid AceDoPC(®)
por: Hachem, Mayssa, et al.
Publicado: (2020) -
Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid
por: Beyer, María Paz, et al.
Publicado: (2023)